Medinippon Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.60 Cr
as on 17-11-2024
- Paid Up Capital ₹ 1.52 Cr
as on 17-11-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 8.61%
(FY 2023)
- Profit 48.22%
(FY 2023)
- Ebitda 51.35%
(FY 2023)
- Net Worth -32.78%
(FY 2023)
- Total Assets -24.17%
(FY 2023)
About Medinippon Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.60 Cr and a paid-up capital of Rs 1.52 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajappa Kumar, Josephine Asantha, and Valan Michael serve as directors at the Company.
- CIN/LLPIN
U33119TN2013PTC093713
- Company No.
093713
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medinippon Healthcare Private Limited offer?
Medinippon Healthcare Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, ICU Equipments.
Who are the key members and board of directors at Medinippon Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajappa Kumar  | Director | 02-Jun-2014 | Current |
| Josephine Asantha | Director | 01-Dec-2018 | Current |
| Valan Michael | Director | 01-Dec-2018 | Current |
Financial Performance of Medinippon Healthcare.
Medinippon Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 8.61% increase. The company also saw a substantial improvement in profitability, with a 48.22% increase in profit. The company's net worth observed a substantial decline by a decrease of 32.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medinippon Healthcare?
In 2023, Medinippon Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nichi-In Bio-Sciences Private LimitedActive 24 years 6 monthsRajappa Kumar, Josephine Asantha and 1 more are mutual person
- Nichi-Hepz Kenko Services Private LimitedActive 24 years 4 months
Rajappa Kumar, Josephine Asantha and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medinippon Healthcare?
Unlock and access historical data on people associated with Medinippon Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medinippon Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medinippon Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
